These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2458747)

  • 1. The effects of co-administration of selenium and cis-platin (CDDP) on CDDP-induced toxicity and antitumour activity.
    Ohkawa K; Tsukada Y; Dohzono H; Koike K; Terashima Y
    Br J Cancer; 1988 Jul; 58(1):38-41. PubMed ID: 2458747
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attenuating the toxicity of cisplatin by using selenosulfate with reduced risk of selenium toxicity as compared with selenite.
    Zhang J; Peng D; Lu H; Liu Q
    Toxicol Appl Pharmacol; 2008 Feb; 226(3):251-9. PubMed ID: 17950769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on protective effect of selenium on the nephrotoxicity of cis-diamminedichloroplatinum (CDDP) in mice].
    Araya Y
    Hokkaido Igaku Zasshi; 1990 May; 65(3):245-53. PubMed ID: 2165995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy of human yolk sac tumor heterotransplanted in nude mice.
    Sawada M; Matsui Y; Okudaira Y
    J Natl Cancer Inst; 1983 Dec; 71(6):1221-5. PubMed ID: 6197552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy of endodermal sinus tumour (yolk sac tumour) of the ovary: preliminary communication.
    Wiltshaw E; Gowing NF; Stuart-Harris R; Raju S; Barker GH
    J R Soc Med; 1982 Nov; 75(11):888-92. PubMed ID: 6183426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sodium selenosulfate at an innocuous dose markedly prevents cisplatin-induced gastrointestinal toxicity.
    Li J; Sun K; Ni L; Wang X; Wang D; Zhang J
    Toxicol Appl Pharmacol; 2012 Feb; 258(3):376-83. PubMed ID: 22172630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selenium efficiently depressed toxic side effect of cis-diamminedichloroplatinum.
    Naganuma A; Satoh M; Yokoyama M; Imura N
    Res Commun Chem Pathol Pharmacol; 1983 Oct; 42(1):127-34. PubMed ID: 6685904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Suppression of CDDP-induced renal toxicity by sodium selenite].
    Yokoyama M; Naganuma A; Imura N
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1225-30. PubMed ID: 4057578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selenite on renal toxicity and antitumor activity of cis-diamminedichloroplatinum in mice inoculated with Ehrlich ascites tumor cell.
    Naganuma A; Satoh M; Imura N
    J Pharmacobiodyn; 1984 Mar; 7(3):217-20. PubMed ID: 6540302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced therapeutic efficacy of cisplatin by combination with diethyldithiocarbamate and hyperthermia in a mouse model.
    Murthy MS; Rao LN; Khandekar JD; Scanlon EF
    Cancer Res; 1987 Feb; 47(3):774-9. PubMed ID: 3026616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antitumour effect and toxicity of cis-platinum and N-methylformamide in combination.
    Harpur ES; Langdon SP; Fathalla SA; Ishmael J
    Cancer Chemother Pharmacol; 1986; 16(2):139-47. PubMed ID: 3948299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduction of cisplatin toxicity and lethality by sodium malate in mice.
    Ueda H; Sugiyama K; Yokota M; Matsuno K; Ezaki T
    Biol Pharm Bull; 1998 Jan; 21(1):34-43. PubMed ID: 9477166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin.
    Giacomelli S; Gallo D; Apollonio P; Ferlini C; Distefano M; Morazzoni P; Riva A; Bombardelli E; Mancuso S; Scambia G
    Life Sci; 2002 Feb; 70(12):1447-59. PubMed ID: 11883719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary.
    Sessa C; Bonazzi C; Landoni F; Pecorelli S; Sartori E; Mangioni C
    Obstet Gynecol; 1987 Aug; 70(2):220-4. PubMed ID: 2439966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumour activity and side effects of combined treatment with chitosan and cisplatin in sarcoma 180-bearing mice.
    Kimura Y; Onoyama M; Sera T; Okuda H
    J Pharm Pharmacol; 2000 Jul; 52(7):883-90. PubMed ID: 10933140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of a newly developed platinum compound cis-1, 1-cyclobutane dicarboxylato-(2R)-2-methyl-1,4-butane diamine platinum (II), on human ovarian tumors transplanted into nude mice].
    Sawada M; Ozaki M; Taniguchi H; Tateishi R; Mori Y; Mino K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):637-41. PubMed ID: 3355185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumour activity of platinum analogues against human yolk sac tumours heterotransplanted in nude mice.
    Sawada M; Matsui Y; Okudaira Y
    Br J Cancer; 1986 Mar; 53(3):415-7. PubMed ID: 3516194
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination cisplatin, vinblastine, and bleomycin chemotherapy (PVB) for malignant germ-cell tumors of the ovary.
    Carlson RW; Sikic BI; Turbow MM; Ballon SC
    J Clin Oncol; 1983 Oct; 1(10):645-51. PubMed ID: 6199468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of a new anti-cancer drug regimen for endometrial cancer].
    Fushiki H; Hidaka T; Hori S; Fujimura M; Yamakawa Y; Izumi R
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):75-8. PubMed ID: 9464332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase I and pharmacokinetic study of temozolomide and cisplatin in patients with advanced solid malignancies.
    Britten CD; Rowinsky EK; Baker SD; Agarwala SS; Eckardt JR; Barrington R; Diab SG; Hammond LA; Johnson T; Villalona-Calero M; Fraass U; Statkevich P; Von Hoff DD; Eckhardt SG
    Clin Cancer Res; 1999 Jul; 5(7):1629-37. PubMed ID: 10430061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.